Stocks

Why Canopy Growth Corp stock is sliding today

By Wealth Awesome Newsroom -
Stocks & ETFs:WEED.TO
Photos provided by Pexels

Canopy Growth Corp's stock took a hit today, dropping 3.60% amid ongoing challenges despite recent revenue growth.

Canopy Growth Corp (WEED.TO) is experiencing a downturn in its stock price, closing at CA$1.34 after a 3.60% decline in the last trading session. This drop comes despite the company's recent announcements of revenue growth and strategic acquisitions aimed at stabilizing its operations.

Investor takeaway: While Canopy Growth is making strides towards profitability with improved revenue figures, today's stock decline highlights the ongoing volatility and investor skepticism surrounding its recovery efforts.

Advertisement

Qtrade Direct Investing

Get up to $2,000 cash back

Open and fund a new Qtrade account with promo code SPRING26. Offer ends July 31, 2026.

Canopy Growth Corp

WEED.TO

Full stock page โ†’

WEED.TO

Canopy Growth Corp

Source:WealthAwesomeWealthAwesome
โ†“ $0.28 (-17.28%)
120 day period
$1.20$1.54$1.89Jan 19Apr 17Jul 14

Market cap

$614.33M

52W high

$3.28

52W low

$1.18

1W change

-1.47%

Beta

2.42

Analyst Price Targets

Based on analyst covering WEED

๐Ÿ“ˆ

Wall Street analysts forecast WEED stock price to rise 50.7% over the next 12 months.

Consensus

Bullish

Based on avg. target vs last close (formal rating unavailable for Canadian listings)

Avg. Target

C$2.02

+50.7% Upside

Current Price

C$1.34

Last close

Analyst ratings and price targets are updated periodically. Not financial advice.

Wealth Awesome Price Forecast

WA Model

Statistical 90-day price range based on WEED's historical volatility

HistoricalForecast68%95%
C$0.69C$0.94C$1.19C$1.44C$1.69C$1.95TodayMar 3May 8Jul 14Aug 26Oct 9Nov 21

30-Day Vol

38.4%

Annualized

90-Day Vol

64.4%

Annualized

Trend (90d)

-50.0%

Annualized drift

90d Mean

C$1.12

Expected price

HorizonExpected68% Range (1ฯƒ)
30 trading daysC$1.26C$1.11 โ€“ C$1.44
60 trading daysC$1.19C$0.99 โ€“ C$1.43
90 trading daysC$1.12C$0.89 โ€“ C$1.41

Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ยฑ1ฯƒ, 95% band = ยฑ2ฯƒ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.

Canopy Growth Corp down 3.60% in a single day.

The stock has fallen more than 33% over the past year, indicating significant ongoing challenges for the cannabis producer.

Bull case

Canopy's recent acquisition of MTL Cannabis and a 14% revenue increase in Q4 show promise for future growth and market leadership in the Canadian medical cannabis sector. This could position the company well as it navigates the competitive landscape.

Bear case

Despite recent improvements, Canopy's stock has lost over 33% in the past year. This reflects ongoing concerns about its profitability and the impact of integration costs on margins, which could hinder its recovery efforts.

Recent Performance Overview

Canopy Growth Corp's stock has been on a rollercoaster, with a notable 3.60% drop today, bringing its closing price to CA$1.34. This decline follows a year where the stock has lost over 33% of its value, raising concerns among investors about the company's long-term viability. Despite reporting a 14% revenue increase in its latest quarter, the market reaction suggests that investors are wary of the challenges that lie ahead.

Challenges Ahead

The recent dip in Canopy's stock price underscores the challenges the company faces, including the integration costs associated with its acquisition of MTL Cannabis. While the acquisition is expected to strengthen Canopy's position in the Canadian medical cannabis market, the immediate impact on margins has been negative, with significant inventory charges affecting profitability. Investors will be closely monitoring the company's ability to achieve positive adjusted EBITDA in the upcoming fiscal year.

Looking Forward

Despite today's setback, Canopy Growth is focusing on its long-term strategy, which includes expanding its presence in international markets and enhancing its product offerings. The company's leadership remains optimistic about its trajectory, citing a strong cash position and potential for growth in Europe and the U.S. However, with persistent regulatory and competitive pressures, the path to recovery may be fraught with obstacles.

Advertisement

Sponsored links

Advertisement